Research ArticleArticle
Serum Soluble Bone Turnover Biomarkers in Psoriatic Arthritis and Psoriatic Spondyloarthropathy
Deepak R. Jadon, Alison L. Nightingale, Neil J. McHugh, Mark A. Lindsay, Eleanor Korendowych and Raj Sengupta
The Journal of Rheumatology November 2014, jrheum.140223; DOI: https://doi.org/10.3899/jrheum.140223
Deepak R. Jadon
From the Royal National Hospital for Rheumatic Diseases, and the University of Bath, Bath, UK. Supported by an unrestricted educational grant from Pfizer Pharmaceuticals. D.R. Jadon, MRCP, Research Fellow, Rheumatology; E. Korendowych, FRCP, Consultant Rheumatologist; R. Sengupta, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases; A.L. Nightingale, PhD, Research Fellow; M.A. Lindsay, PhD, Professor, Pharmacy and Pharmacology, University of Bath; N.J. McHugh, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases, and the University of Bath. Address correspondence to Dr. D.R. Jadon, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, UK. E-mail: jadondr@yahoo.com. Accepted for publication September 2, 2014.
Alison L. Nightingale
From the Royal National Hospital for Rheumatic Diseases, and the University of Bath, Bath, UK. Supported by an unrestricted educational grant from Pfizer Pharmaceuticals. D.R. Jadon, MRCP, Research Fellow, Rheumatology; E. Korendowych, FRCP, Consultant Rheumatologist; R. Sengupta, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases; A.L. Nightingale, PhD, Research Fellow; M.A. Lindsay, PhD, Professor, Pharmacy and Pharmacology, University of Bath; N.J. McHugh, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases, and the University of Bath. Address correspondence to Dr. D.R. Jadon, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, UK. E-mail: jadondr@yahoo.com. Accepted for publication September 2, 2014.
Neil J. McHugh
From the Royal National Hospital for Rheumatic Diseases, and the University of Bath, Bath, UK. Supported by an unrestricted educational grant from Pfizer Pharmaceuticals. D.R. Jadon, MRCP, Research Fellow, Rheumatology; E. Korendowych, FRCP, Consultant Rheumatologist; R. Sengupta, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases; A.L. Nightingale, PhD, Research Fellow; M.A. Lindsay, PhD, Professor, Pharmacy and Pharmacology, University of Bath; N.J. McHugh, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases, and the University of Bath. Address correspondence to Dr. D.R. Jadon, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, UK. E-mail: jadondr@yahoo.com. Accepted for publication September 2, 2014.
Mark A. Lindsay
From the Royal National Hospital for Rheumatic Diseases, and the University of Bath, Bath, UK. Supported by an unrestricted educational grant from Pfizer Pharmaceuticals. D.R. Jadon, MRCP, Research Fellow, Rheumatology; E. Korendowych, FRCP, Consultant Rheumatologist; R. Sengupta, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases; A.L. Nightingale, PhD, Research Fellow; M.A. Lindsay, PhD, Professor, Pharmacy and Pharmacology, University of Bath; N.J. McHugh, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases, and the University of Bath. Address correspondence to Dr. D.R. Jadon, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, UK. E-mail: jadondr@yahoo.com. Accepted for publication September 2, 2014.
Eleanor Korendowych
From the Royal National Hospital for Rheumatic Diseases, and the University of Bath, Bath, UK. Supported by an unrestricted educational grant from Pfizer Pharmaceuticals. D.R. Jadon, MRCP, Research Fellow, Rheumatology; E. Korendowych, FRCP, Consultant Rheumatologist; R. Sengupta, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases; A.L. Nightingale, PhD, Research Fellow; M.A. Lindsay, PhD, Professor, Pharmacy and Pharmacology, University of Bath; N.J. McHugh, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases, and the University of Bath. Address correspondence to Dr. D.R. Jadon, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, UK. E-mail: jadondr@yahoo.com. Accepted for publication September 2, 2014.
Raj Sengupta
From the Royal National Hospital for Rheumatic Diseases, and the University of Bath, Bath, UK. Supported by an unrestricted educational grant from Pfizer Pharmaceuticals. D.R. Jadon, MRCP, Research Fellow, Rheumatology; E. Korendowych, FRCP, Consultant Rheumatologist; R. Sengupta, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases; A.L. Nightingale, PhD, Research Fellow; M.A. Lindsay, PhD, Professor, Pharmacy and Pharmacology, University of Bath; N.J. McHugh, FRCP, Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases, and the University of Bath. Address correspondence to Dr. D.R. Jadon, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, UK. E-mail: jadondr@yahoo.com. Accepted for publication September 2, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Serum Soluble Bone Turnover Biomarkers in Psoriatic Arthritis and Psoriatic Spondyloarthropathy
Deepak R. Jadon, Alison L. Nightingale, Neil J. McHugh, Mark A. Lindsay, Eleanor Korendowych, Raj Sengupta
The Journal of Rheumatology Nov 2014, jrheum.140223; DOI: 10.3899/jrheum.140223